Cargando…
Determination of caspase-3 activation fails to predict chemosensitivity in primary acute myeloid leukemia blasts
BACKGROUND: Ex-vivo chemosensitivity tests that measure cell death induction may predict treatment outcome and, therefore, represent a powerful instrument for clinical decision making in cancer therapy. Such tests are, however, work intensive and, in the case of the DiSC-assay, require at least four...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2005
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1164407/ https://www.ncbi.nlm.nih.gov/pubmed/15949045 http://dx.doi.org/10.1186/1471-2407-5-60 |